These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26826771)

  • 21. [Idiopathic overactive bladder: What to do in case of anticholinergic failure?].
    Boudy AS; Thubert T
    Prog Urol; 2015 Jun; 25(8):497-8. PubMed ID: 25748787
    [No Abstract]   [Full Text] [Related]  

  • 22. WITHDRAWN: Anticholinergics for urinary symptoms in multiple sclerosis.
    Nicholas RS; Friede T; Hollis S; Young CA
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD004193. PubMed ID: 26043867
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of Anticholinergic Drugs Used for the Therapy of Overactive Bladder on P-Glycoprotein Activity.
    Wakuda H; Okura T; Maruyama-Fumoto K; Kagota S; Ito Y; Miyauchi-Wakuda S; Otani N; Uemura N; Yamada S; Shinozuka K
    Biol Pharm Bull; 2019; 42(12):1996-2001. PubMed ID: 31787715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impact of body mass index on lower urinary tract disorders in multiple sclerosis].
    Miget G; Hentzen C; Turmel N; Chesnel C; Charlanes A; Le Breton F; Amarenco G
    Prog Urol; 2019 Jul; 29(7):366-370. PubMed ID: 31133495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trospium chloride: Distinct among other anticholinergic agents available for the treatment of overactive bladder.
    Staskin DR
    Urol Clin North Am; 2006 Nov; 33(4):465-73, viii. PubMed ID: 17011382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maximizing anticholinergic therapy for overactive bladder: has the ceiling been reached?
    MacDiarmid SA
    BJU Int; 2007 Jun; 99 Suppl 3():8-12. PubMed ID: 17488367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence, persistence and switch rates for anticholinergic drugs used for overactive bladder in women: data from the Norwegian Prescription Database.
    Mauseth SA; Skurtveit S; Spigset O
    Acta Obstet Gynecol Scand; 2013 Oct; 92(10):1208-15. PubMed ID: 23763552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS Patient Registry.
    Mahajan ST; Patel PB; Marrie RA
    J Urol; 2010 Apr; 183(4):1432-7. PubMed ID: 20171697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autonomic nervous system alteration in multiple sclerosis patients with urinary symptoms. Clinical, urodynamic and cardiovascular study].
    Amarenco G; Raibaut P; Hubeaux K; Jousse M; Sheikh Ismaël S; Lapeyre E
    Prog Urol; 2013 Dec; 23(17):1505-10. PubMed ID: 24286553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solifenacin for overactive bladder in women unsuccessfully treated with immediate release oxybutynin: a pilot study.
    Wong C; Duggan P
    J Obstet Gynaecol; 2009 Jan; 29(1):31-4. PubMed ID: 19280492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial combined treatment with anticholinergics and α-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study.
    Lee SH; Chung BH; Kim SJ; Kim JH; Kim JC; Lee JY
    Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):320-5. PubMed ID: 21788967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overactive Bladder.
    White N; Iglesia CB
    Obstet Gynecol Clin North Am; 2016 Mar; 43(1):59-68. PubMed ID: 26880508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of symptom improvement on patients' bother and quality of life in female patients with overactive bladder treated by solifenacin (SET-Q).
    Gotoh M; Kobayashi T; Sogabe K
    Int J Urol; 2014 May; 21(5):505-11. PubMed ID: 24304092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive changes in women starting anticholinergic medications for overactive bladder: a prospective study.
    Iyer S; Lozo S; Botros C; Wang C; Warren A; Sand P; Tomezsko J; Botros S; Gafni-Kane A; Sasso K; Goldberg RP
    Int Urogynecol J; 2020 Dec; 31(12):2653-2660. PubMed ID: 31813036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urodynamic approach to female urinary incontinence refractory to treatment with anticholinergics.
    Naranjo-Ortiz C; Clemente-Ramos LM; Salinas-Casado J; Méndez-Rubio S
    Arch Esp Urol; 2012 Dec; 65(10):879-86. PubMed ID: 23269334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sexual function in women with overactive bladder.
    Zahariou A; Karamouti M; Tyligada E; Papaioannou P
    Female Pelvic Med Reconstr Surg; 2010 Jan; 16(1):31-6. PubMed ID: 22453087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Differences of urodynamic tests between patients of detrusor hyperactivity with impaired contractility with and without bladder outlet obstruction and effect of anticholinergic medications in these patients].
    Liu N; He F; Man LB; Huang GL; Wang HD; Wang H; Li GZ; Wang JW
    Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(26):1824-7. PubMed ID: 22944232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sexuality experiences of women with multiple sclerosis reporting overactive bladder: a qualitative study.
    Dunya CP; Özkan İ; Demir S
    J Sex Med; 2023 Aug; 20(9):1172-1179. PubMed ID: 37563847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cognitive adverse effects of anticholinergic medication for overactive bladder in PD/DLB].
    Sakakibara R
    Rinsho Shinkeigaku; 2013; 53(11):1389-92. PubMed ID: 24292000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticholinergic prescription: are healthcare professionals the real burden?
    Araklitis G; Thiagamoorthy G; Hunter J; Rantell A; Robinson D; Cardozo L
    Int Urogynecol J; 2017 Aug; 28(8):1249-1256. PubMed ID: 28091711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.